ZEB1 and cardiac hypertrophy: Our results strongly suggest that BZP is a potential drug candidate for treatment of pressure overload‐induced cardiac hypertrophy, and its therapeutic effect might be associated with inhibition of maladaptive cardiomyocyte autophagy.